Vaccine Therapy in Treating Patients With Malignant Melanoma

Clinical trial NCT00128583 · UNKNOWN

Trial details

NCT number: NCT00128583
Sponsor: CancerVax Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2005-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.